Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib + capecitabine vs placebo + capecitabine in HER2-negative advanced breast cancer
CTR20132870Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sorafenib in breast cancer, sponsored by Bayer. Started Apr 2014; status: completed.
02
Drugs
sorafenib
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20132870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132870.